Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY:BDX)

177.30 -1.41 (-0.79%)
Official Closing Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSE:BDX)... 
Via StockStory
Topics Artificial Intelligence Economy
10 KISS Stocks For Reliable Retirement Income
Retirement investing should be kept simple in order to minimize mistakes. At its core, retirement investing is all about creating passive income. 
Via Talk Markets
Topics Retirement Stocks / Equities
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Economy
3 Reasons to Sell BDX and 1 Stock to Buy Instead
Over the past six months, BD’s shares (currently trading at $224.85) have posted a disappointing 5.9% loss, well below the S&P 500’s 5.1% gain. This might have investors contemplating their next move. 
Via StockStory
Topics Stocks
Price Over Earnings Overview: Becton Dickinson
 
Via Benzinga
(BDX) - Analyzing Becton Dickinson's Short Interest
 
Via Benzinga
(BDX) - Analyzing Becton Dickinson's Short Interest
 
Via Benzinga
Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings
Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting results tomorrow afternoon. Here’s what to look for. 
Via StockStory
3 Dividend Stocks Trading At A Discount
These 3 dividend stocks have increased their dividends for over 50 years and are trading at a discounted valuation. 
Via Talk Markets
Topics Stocks / Equities
10 Overlooked Dividend Powerhouses Trading At A Discount
Via Talk Markets
Topics Stocks / Equities
Healthcare And Biotech Playbook As Disruption Gathers Force
The XBI was down 1.54% for the week, like off a cliff on Friday from a Wednesday high of $94.82. 
Via Talk Markets
Topics ETFs Stocks / Equities
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business
Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance. 
Via Benzinga
Price Over Earnings Overview: Becton Dickinson
 
Via Benzinga
A Glimpse Into The Expert Outlook On Becton Dickinson Through 4 Analysts
 
Via Benzinga
BD (BDX) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be announcing earnings results tomorrow before market open. Here’s what to look for. 
Via StockStory
Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit
Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to... 
Via Benzinga
Biotech And Healthcare Stocks Poised For Gains Ahead
The XLV bounced off the bottom this month up 4% to the $144 level led by biopharma and medtech. 
Via Talk Markets
Topics ETFs Stocks / Equities
5 S&P 500 Stocks Set To Shine In The Final Week Of January — If History Repeats Itself
S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI investments. 
Via Benzinga
Topics Artificial Intelligence Government Stocks
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
From Biosero, Inc.
Via Business Wire
5 Stocks to Sell Before Trump's Mexico Tariffs
Stocks to sell ahead of tariffs on Mexico: General Motors and Whirlpool have significant exposure to Mexican production facilities. 
Via Benzinga
Topics Government World Trade
Two Big Weeks To Play A Rally In Biotech And Healthcare Stocks
The healthcare sector is lagging over the past year and recent quarter with the XLV flat for 2024 and down over 4% for the recent quarter. 
Via Talk Markets
Topics ETFs Stocks / Equities
10 Buy And Hold Forever Dividend Stocks
The following 10 stocks represent Dividend Kings that can continue to raise their dividends for decades to come. 
Via Talk Markets
Topics Stocks / Equities
Financial Crime Weekly: Becton, Dickinson And Co. Pays $175 Million Penalty, Express Fails To Disclose CEO's Full Compensation
Becton, Dickinson and Co. pays a $175 million civil penalty and Express fails to disclose its former CEO's full compensation. 
Via Benzinga
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
13 Healthcare Sector Stocks With Healthy Valuation
We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty... 
Via Talk Markets
Topics Stocks Stocks / Equities
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps
Embecta reports fourth quarter earnings beating estimates, discontinues insulin patch program, and announces restructuring plans with cost-saving measures. 
Via Benzinga
Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
Altria Group is "undervalued," Cramer says. On Oct. 31, the company reported third-quarter adjusted earnings per share of $1.38. 
Via Benzinga
Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike
The U.S. 
Via Benzinga
Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth
BD's Q4 sales rose 6.9% to $5.44 billion, beating estimates. EPS of $3.81 also topped forecasts. FY25 guidance includes $21.9 billion-$22.1 billion sales and EPS of $14.25-$14.60. 
Via Benzinga
Medtronic Inc. Dividend Stock Analysis - Sunday, Sept. 29
Medtronic Inc. is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management, and other medical markets. Here are some highlights... 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.